You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
The Harvard Drug Group LLCFDAMed source confidence · 83%Jul 7, 2026, 9:02 PM UTC · 17h ago

The Harvard Drug Group LLC — FDA Class II (D-0609-2026)

Case File

The Harvard Drug Group LLC is recalling 790 cartons of the oral prescription drug Methyl due to contamination issues. This recall is classified as a safety concern. The affected products were distributed nationwide.

Sign in to follow The Harvard Drug Group LLC and get alerts like this
Key Points
  • The Harvard Drug Group LLC is recalling 790 cartons of Methyl.
  • The recall is due to contamination concerns.
  • The drug is taken orally and is a prescription medication.
  • Patients should check their medicine cabinets for this product.
  • Class I recalls indicate serious health risks.
Why This Matters

Patients using Methyl should stop using it immediately due to contamination risks. They should check for 790 cartons affected by this recall.

View original filing →
Sign in to follow The Harvard Drug Group LLC and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.